Regeneron Pharmaceuticals, Inc.
Human serum albumin in formulations

Last updated:

Abstract:

Drug formulations and methods for removing, reducing, or preventing the formation of fatty acid particles in drug formulations are provided.

Status:
Grant
Type:

Utility

Filling date:

3 Mar 2020

Issue date:

8 Feb 2022